Description
The program aims to achieve better patient health outcomes, support optimal use of biological and small molecule medicines and contribute to Pharmaceutical Benefits Scheme sustainability across a range of specialty areas including gastroenterology, rheumatology and dermatology.
Presented at GESA AGW 2021